Northborough, MA, United States of America

Bradford L McRae

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Bradford L. McRae: A Pioneering Inventor in Antibody Technology

Introduction

Bradford L. McRae is an accomplished inventor based in Northborough, MA, known for his significant contributions to the field of biotechnology. With a portfolio of six patents, he has been instrumental in advancing therapeutic approaches involving antibodies, particularly in the treatment of disorders related to the immune system.

Latest Patents

Among his latest innovations are two notable patents: the first involves anti-CD40 antibodies, which are designed to inhibit human CD40 activity. This invention plays a crucial role in treating conditions where CD40 activity is harmful. The second patent focuses on IL-17 binding proteins, which are essential in developing treatments and diagnostic methods for IL-17 related diseases.

Career Highlights

Bradford has worked with renowned pharmaceutical companies such as AbbVie Inc. and Abbott Laboratories Corporation, where he has honed his expertise and contributed to groundbreaking research. His work has been recognized for pushing the boundaries of scientific knowledge and its practical applications in medicine.

Collaborations

Throughout his career, Bradford has collaborated with esteemed colleagues, including Chung-Ming Hsieh and Yuliya Kutskova. Their combined efforts contribute to the innovation and development of novel therapeutic strategies that continue to impact the field.

Conclusion

As a dedicated inventor, Bradford L. McRae's contributions in the realm of antibody technology are invaluable. His patents not only illustrate his technical prowess but also showcase his commitment to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…